Concepedia

Publication | Open Access

Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial

105

Citations

28

References

2018

Year

Abstract

Liver and lung metastases and a poor performance status are independent predictors of nivolumab efficacy in patients with advanced non-small cell lung cancer.

References

YearCitations

Page 1